Clicky

Ergomed Plc(ERGO)

Description: Ergomed plc is a provider of drug development services to the pharmaceutical industry. The Company operates through two segments: clinical research services (CRS), and drug safety and medical information services (DS&MI). It provides a range of clinical trial planning, management and monitoring services. It is focused on oncology, neurology and immunology, and the development of orphan drugs. It has two businesses: Services Business and Co-Development Business. The Services Business is a clinical research business providing services to the pharmaceutical and biotechnology industry. The Co-Development Business is a portfolio of partnerships with pharmaceutical and biotechnology companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including out licensing milestones, as well as sales of the product. It provides clinical development, trial management and pharmacovigilance services to over 100 clients.


Keywords: Biotechnology Pharmaceutical Drugs Immunology Ships Clinic Oncology Safety Clinical Trial Monitoring Drug Development Clinical Research Planning Partnerships Clinical Pharmacology Contract Research Organizations Clinical Research Services Search Service Pharmacovigilance Drug Development Services Medical Information Services Pharmacovigilance Services

Home Page: www.ergomedplc.com

ERGO Technical Analysis

Surrey Research Park
Guildford, GU2 7HJ
United Kingdom
Phone: 44 1483 503 205


Officers

Name Title
Dr. Miroslav Reljanovic Founder & Exec. Chairman
Mr. Richard T. Barfield CFO & Exec. Director
Mr. Michael William Spiteri Chief Transformation & Technology Officer
Mr. Shaun Hopgood Chief Information Officer
Dr. Michael Forstner Head of Risk Management & Pharmacoepidemiology
Ms. Sally Amanuel Pres of PrimeVigilance
Dr. Gordana Tonkovic Pres of Clinical Research
Ms. Ronel Steyn Sr. VP of Global Devel.
Keith Byrne Sr. Vice-Pres of Capital Markets & Strategy
Jonathan Curtain Deputy CFO

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 27.5482
Trailing PE: 48.2308
Price-to-Book MRQ: 8.6765
Price-to-Sales TTM: 5.0148
IPO Date:
Fiscal Year End: December
Full Time Employees: 1371
Back to stocks